Evidence map›Paper›PMID 34207769›Full record

ArticleInternational journal of molecular sciences2021

Albumin-Coated Single-Core Iron Oxide Nanoparticles for Enhanced Molecular Magnetic Imaging (MRI/MPI).

Abdulkader Baki, Amani Remmo, Norbert Löwa, Frank Wiekhorst, Regina Bleul

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 52 citations in OpenAlex.

  1. Starch-Coated Superparamagnetic FeNanomaterials (Basel, Switzerland) · 2026
    Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Hemocompatibility of Albumin-Modified Magnetic Nanoparticles.International journal of molecular sciences · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Abdulkader BakiFraunhofer Institute for Microengineering and Microsystems IMM, Carl-Zeiss-Straße 18-20, 55129 Mainz, Germany.
Amani RemmoPhysikalisch-Technische Bundesanstalt, Abbestraße 2-12, 10587 Berlin, Germany.ORCID 0000-0003-4171-5283
Norbert LöwaPhysikalisch-Technische Bundesanstalt, Abbestraße 2-12, 10587 Berlin, Germany.ORCID 0000-0001-6245-9042
Frank WiekhorstPhysikalisch-Technische Bundesanstalt, Abbestraße 2-12, 10587 Berlin, Germany.ORCID 0000-0003-0608-1473
Regina BleulFraunhofer Institute for Microengineering and Microsystems IMM, Carl-Zeiss-Straße 18-20, 55129 Mainz, Germany.ORCID 0000-0003-0352-7193
Physikalisch-Technische Bundesanstalt · DECarl Zeiss (Germany) · DE

Funding

Bundesministerium für Bildung und Forschung 13XP5113Deutsche Forschungsgemeinschaft KO5321/3Deutsche Forschungsgemeinschaft SFB 1340/1 2018, no 372486779, projects A02Deutsche Forschungsgemeinschaft TR408/11
6 · The paper itself

Abstract

Colloidal stability of magnetic iron oxide nanoparticles (MNP) in physiological environments is crucial for their (bio)medical application. MNP are potential contrast agents for different imaging modalities such as magnetic resonance imaging (MRI) and magnetic particle imaging (MPI). Applied as a hybrid method (MRI/MPI), these are valuable tools for molecular imaging. Continuously synthesized and in-situ stabilized single-core MNP were further modified by albumin coating. Synthesizing and coating of MNP were carried out in aqueous media without using any organic solvent in a simple procedure. The additional steric stabilization with the biocompatible protein, namely bovine serum albumin (BSA), led to potential contrast agents suitable for multimodal (MRI/MPI) imaging. The colloidal stability of BSA-coated MNP was investigated in different sodium chloride concentrations (50 to 150 mM) in short- and long-term incubation (from two hours to one week) using physiochemical characterization techniques such as transmission electron microscopy (TEM) for core size and differential centrifugal sedimentation (DCS) for hydrodynamic size. Magnetic characterization such as magnetic particle spectroscopy (MPS) and nuclear magnetic resonance (NMR) measurements confirmed the successful surface modification as well as exceptional colloidal stability of the relatively large single-core MNP. For comparison, two commercially available MNP systems were investigated, MNP-clusters, the former liver contrast agent (Resovist), and single-core MNP (SHP-30) manufactured by thermal decomposition. The tailored core size, colloidal stability in a physiological environment, and magnetic performance of our MNP indicate their ability to be used as molecular magnetic contrast agents for MPI and MRI.

Indexed as

Magnetic Resonance ImagingAnimalsCattleCoated Materials, BiocompatibleContrast MediaMagnetic Iron Oxide NanoparticlesSerum Albumin, BovineCoated Materials, BiocompatibleContrast MediaSerum Albumin, Bovineiron oxide nanoparticlesmagnetic particle imagingmagnetic particle spectroscopymagnetic resonance imagingserum albumin

Identifiers

PMID34207769
PMCPMC8229057
OpenAlexW3168240509

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.